Therefore, ProCT may reasonably be considered as a complementary marker in patients with thyroid nodules and positive calcitonin results (as a rule-out test) and in MTC patients with unclear postoperative calcitonin trends. The gene discussed is CALCA; the disease is thyroid nodule.